Baxter International Inc (NYSE:BAX)
$ 29.08 -0.1 (-0.34%) Market Cap: 14.85 Bil Enterprise Value: 26.69 Bil PE Ratio: 145.40 PB Ratio: 1.89 GF Score: 74/100

Baxter International Inc at UBS Genomics 2.0 and MedTech Innovations Summit Transcript

Aug 12, 2021 / 05:00PM GMT
Release Date Price: $73.86 (-0.16%)
Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

Okay. Great. So welcome to our next session here in person with the management from Baxter. We've got Jay Saccaro, EVP and CFO of the company; and Clare Trachtman, VP of IR. So Jay and Clare, thanks for making the trip. Welcome to the live stage, the first time in a couple of years, so it's very exciting, and looking forward to the conversation.

Questions & Answers

Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

So let me come and sit down with you. So first, I just wanted to start with a high-level question for you, Jay, and maybe just talk about your vision for Baxter over the next few years. Without giving away the Analyst Day takeaways, could you talk at a high level about how you see the evolution of Baxter post-COVID?

James K. Saccaro
Baxter International Inc. - Executive VP & CFO

Sure, Matt. And it's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot